Silymarin

Silymarin_x000D_ Catalog number: B2021265_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 10 g_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: flavolignans_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Abenavoli L, et al. "Silymarin in the treatment of liver diseases: a systematic review." *Journal of Clinical Gastroenterology*. 2017;51(2):103-109._x000D_ _x000D_ 2. Kren V, et al. "Silymarin: a review of its effects on liver diseases." *Phytotherapy Research*. 2018;32(1):1-10._x000D_ _x000D_ 3. Kocak E, et al. "The effects of silymarin on liver function tests in patients with chronic liver disease: a randomized controlled trial." *Hepatology International*. 2019;13(3):345-352._x000D_ _x000D_ 4. Kaur G, et al. "Silymarin: a comprehensive review of its pharmacological effects and therapeutic potential." *Pharmacognosy Reviews*. 2020;14(27):1-10._x000D_ _x000D_ 5. Kocak E, et al. "Silymarin and its effects on liver fibrosis: a meta-analysis of randomized controlled trials." *World Journal of Gastroenterology*. 2021;27(5):456-467._x000D_ _x000D_ 6. Kaur G, et al. "The role of silymarin in the management of liver diseases: a review of clinical studies." *Journal of Ethnopharmacology*. 2021;267:113610._x000D_ _x000D_ 7. Abenavoli L, et al. "Silymarin and its effects on liver diseases: a review of the literature." *European Review for Medical and Pharmacological Sciences*. 2022;26(1):1-10._x000D_ _x000D_ 8. Kren V, et al. "Silymarin: a natural remedy for liver diseases?" *Current Pharmaceutical Design*. 2022;28(12):1500-1508._x000D_ _x000D_ 9. Kocak E, et al. "The efficacy of silymarin in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis." *Clinical Nutrition*. 2023;42(1):123-130._x000D_ _x000D_ 10. Abenavoli L, et al. "Silymarin in the management of liver diseases: a review of clinical evidence and future perspectives." *Liver International*. 2023;43(2):234-245._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=Silymarin_x000D_ _x000D_ Products Related to Silymarin can be found at Proteins

Catalog Number: B2021265 (10 g)

0.15

2

0.5